Bharat Biotech

New Delhi: Lauding the final approval of the Drugs Controller General of India (DCGI) on Sunday to two COVID-19 vaccines, All India Institute Of Medical Science (AIIMS) Director Randeep Guleria said, the indigenously developed Covaxin,…

New Delhi: India has finally got its vaccine against coronavirus. Two vaccines — Pune-based Serum Institute’s Covishield and Bharat Biotech's Covaxin — received emergency use approval from the Drugs Controller General of India (DCGI) on…

New Delhi: The All India Drug Action Network (AIDAN) has asked the Drugs Controller General of India (DCGI) to reconsider SEC recommendation in granting REU approval to Bharat Biotech-developed COVAXIN. According to the AIDAN, it is…

New Delhi: A day after the Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) recommended granting permission for emergency use of the Oxford vaccine, the expert panel on Saturday gave…

Hyderabad: COVID-19 vaccine, Covaxin will be effective in treating the new strain that has created a panic worldwide, Bharat Biotech said on Tuesday. According to Bharat Biotech Chairman and Managing Director Krishna Ella, the protein…

New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, ZeeNews…

New Delhi: The Union government dismissed media reports of Serum Institute India (SII) and Bharat Biotech’s emergency use authorisation of COVID-19 vaccine being rejected and called it “fake.” According to a report earlier in the day, SII…

New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus vaccine because of inadequate safety and efficacy data. According to sources, a panel of experts have asked…

Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI). Now, Hyderabad-based Bharat Biotech followed suit in urging…

New Delhi: Prime Minister Narendra Modi will visit India’s three pharma majors on Saturday to personally review the development of COVID-19 vaccine and the manufacturing process. “As India enters a decisive phase of the fight against…